USPTO trademark

KRISAFLIS

RegisteredUSPTOWord markClass 5

"KRISAFLIS" is a word mark owned by Glaxo Group Limited, filed at the USPTO on March 18, 2020. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
KRISAFLIS trademark as filed
As filed with the USPTO
Status
Registered
Since December 14, 2021
Filed
March 18, 2020
Registered
December 14, 2021
Expires
Not recorded
Application no.
88838369
Registration no.
6585778
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns KRISAFLIS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GlaxoSmithKline

Goods and services

What the mark covers

The products and services KRISAFLIS is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Applicant/correspondence changes (non-responsive) entered
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About KRISAFLIS

Who owns the trademark "KRISAFLIS"?

The USPTO trademark "KRISAFLIS" (application 88838369) is owned by Glaxo Group Limited.

What is the status of "KRISAFLIS"?

Its status at the USPTO is: registered.

When was "KRISAFLIS" registered?

It was registered on December 14, 2021.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KRISAFLIS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b80-08a2-749f-8ea7-58b39a74c2ac
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b80-08a2-749f-8ea7-58b39a74c2ac",
  "object": "trademark",
  "mark_text": "KRISAFLIS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88838369",
  "filing_date": "2020-03-18",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}